Keyphrases
1-deoxy-D-xylulose 5-phosphate Reductoisomerase
16%
Antibacterial Agents
100%
Antibacterial Drugs
8%
Antimalarial Drugs
100%
Antimicrobial Resistance
8%
Antiparasitic Drugs
8%
Biological Effects
8%
Biological Reagent
8%
Broad Spectrum Antimicrobial Agent
8%
Clinical Trials
8%
Combination Therapy
8%
Complex Biological Samples
8%
Drug Development
8%
Escherichia Coli
8%
Escherichia Coli Bacteria
8%
Eubacteria
8%
Falciparum Malaria
16%
Fosfomycin
100%
Gram-negative Bacteria
8%
Growth Inhibition
8%
Healthcare-associated Infections
8%
Isoprenoid Synthesis
66%
Isoprenoids
8%
IspD
25%
Malaria
8%
Malaria Parasite
8%
Mass Spectrometry Methods
8%
Metabolic Profiling
100%
Metabolic Response
8%
Metabolism
8%
Methylerythritol Phosphate
8%
Non-mevalonate
25%
Non-mevalonate Pathway
8%
Overexpression
8%
Pathogenic Organisms
8%
Plasmodium Falciparum
8%
Serious Infection
8%
Tuberculosis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Resistance
8%
Antiinfective Agent
100%
Antimalarial Agent
100%
Antimicrobial Agent
8%
Antiparasitic Agent
8%
Bacterium
8%
Clinical Trial
8%
Combination Therapy
8%
Drug Development
8%
Escherichia coli
25%
Eubacteria
8%
Fosmidomycin
100%
Gram Negative Bacterium
8%
Healthcare Associated Infection
8%
Infection
8%
Infectious Agent
8%
Isoprenoid
75%
Malaria Falciparum
16%
Mevalonic Acid
33%
Plasmodium
8%
Biochemistry, Genetics and Molecular Biology
Antibiotic Resistance
8%
Bacterium
8%
Biological Activity
8%
Clinical Trial
8%
Enzyme
25%
Escherichia coli
25%
Eubacteria
8%
Fosmidomycin
100%
Gram Negative Bacterium
8%
Growth Inhibition
8%
Infectious Agent
8%
Isoprenoids Biosynthesis
33%
Mass Spectrometry
8%
Metabolic Pathway
50%
Metabolite
16%
Non-Mevalonate Pathway
8%
Plasmodium
8%
Plasmodium falciparum
8%
Immunology and Microbiology